PomDoctor ($POM) Alleged Pump-and-Dump Stock Promotion Scheme Case

S.D. New York

Court

1:26-cv-01013

Case number

10/09/2025

Class period Start

12/11/2025

Class period End

04/06/2026

Lead Plaintiff motion deadline

$POM investors filed a claim against PomDoctor for failing to disclose that the stock’s trading was being artificially inflated by a fraudulent social-media-driven “pump-and-dump” promotion scheme.
After reports and investigations tied $POM’s price spike to alleged manipulation and coordinated dumping, $POM fell about 93% from $5.42 on December 9, 2025 to approximately $0.40 by December 11, 2025.
$POM investors can join this case to be notified about potential recovery.
Case Details:

Between Oct. 9, 2025 and Dec. 11, 2025, PomDoctor told investors it was a leading chronic-disease telehealth platform in China, pointing to revenue growth, strong online-pharmacy performance, and cost discipline in its public filings.

Investors allege that, behind the scenes, $POM’s run-up was fueled by a fraudulent social-media promotion campaign and private chat groups—some tied to impersonators posing as financial professionals—creating artificial buying pressure. They further claim insiders and/or affiliates used offshore or nominee accounts to dump shares while the company failed to disclose the alleged manipulation and misinformation.

As reports and investigations spotlighted the alleged pump-and-dump on Dec. 9–10, 2025, $POM collapsed about 91% to roughly $0.50, and by Dec. 11, 2025 it traded around $0.40, down about 93% from its pre-drop level.

Based on these events, $POM investors filed a claim against PomDoctor, alleging the company:
It failed to disclose that $POM was allegedly being promoted through a fraudulent, social-media-based pump-and-dump scheme
It omitted material facts about alleged insider/affiliate dumping and the role of offshore/nominee accounts and artificial trading activity
It misled investors about the integrity of the market for $POM and the risks affecting its stock price
Investors argue PomDoctor misled the market about the true drivers of $POM’s price and trading activity, causing investor losses when the alleged manipulation unraveled.

Case Type

US Securities Class Action

Case Status

Lead Plaintiff Appointment

Alleged Offence

Misleading Statements,

Financial Misrepresentation,

Fraud,

Failure to Disclose

Suspected Party

Directors,

Management

Security Type

Depository Securities (ADS, ADR, GDR)

Trade Direction

Long

Shock Event Date

12/10/2025

Filing date

02/05/2026

Lead Plaintiff Deadline

04/06/2026

Trusted by industry leaders

Endorsed by top professionals who trust our innovative solutions to drive impactful results.